Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Vancouver, British Columbia, Canada
SEC filing record 1 source field available
Fiscal year end
30 June
InMed Pharmaceuticals Inc. has filed 492 SEC EDGAR filings since 17 Jan 2018

SEC filing history

Showing 51-75 of 492 matching filings.

Per page
25
Current page
3
4

4 filing

Filing date
17 Dec 2025
Reporting date
15 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
15 Dec 2025
Reporting date
12 Dec 2025
Next action
Verify source filing
S-8 File 333-292003

REGISTRATION STATEMENT

Filing date
08 Dec 2025
Reporting date
Not listed
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
19 Nov 2025
Reporting date
18 Nov 2025
Next action
Verify source filing
10-Q File 001-39685

QUARTERLY REPORT

Filing date
06 Nov 2025
Reporting date
30 Sep 2025
Next action
Verify source filing
DEFA14A File 001-39685

DEFINITIVE ADDITIONAL MATERIALS

Filing date
03 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39685

DEFINITIVE PROXY STATEMENT

Filing date
03 Nov 2025
Reporting date
17 Dec 2025
Next action
Verify source filing
PRE 14A File 001-39685

PRELIMINARY PROXY STATEMENT

Filing date
24 Oct 2025
Reporting date
24 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-39685

AMENDMENT NO. 1 TO FORM 10-K

Filing date
24 Oct 2025
Reporting date
30 Jun 2025
Next action
Verify source filing
3

3 filing

Filing date
23 Oct 2025
Reporting date
14 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Oct 2025
Reporting date
17 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
17 Oct 2025
Reporting date
09 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
16 Oct 2025
Reporting date
14 Oct 2025
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
14 Oct 2025
Reporting date
10 Oct 2025
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
14 Oct 2025
Reporting date
09 Oct 2025
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
23 Sep 2025
Reporting date
23 Sep 2025
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
23 Sep 2025
Reporting date
23 Sep 2025
Next action
Verify source filing
10-K File 001-39685

ANNUAL REPORT

Filing date
23 Sep 2025
Reporting date
30 Jun 2025
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
08 Sep 2025
Reporting date
05 Sep 2025
Next action
Verify source filing
424B3 File 333-288594

PROSPECTUS

Filing date
05 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-288594

EFFECT filing

Filing date
01 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-288594

PRE-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1

Filing date
01 Aug 2025
Reporting date
Not listed
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
31 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
28 Jul 2025
Reporting date
28 Jul 2025
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
14 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .